U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885423) titled '68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer' on Oct. 14.
Brief Summary: This study aims to evaluate the feasibility, safety, and diagnostic performance of 68Ga-XMFH01, a novel ACP3-targeted dual-modality PET and fluorescence imaging probe, for preoperative PET/CT imaging and intraoperative fluorescence-guided surgery in patients with prostate cancer.
Study Start Date: Oct. 21
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer (Diagnosis)
ACP3
PET / CT
Intervention:
DIAGNOSTIC_TEST: 68Ga-XMFH01 PET/CT
Each participant will receive a single intravenous injection of 68Ga-XMFH01, a novel HER2-targeted radiotracer, ...